up home page bottom

French German version Spanish version Italian version

header image

British girl dies after cervical cancer vaccination

Edmonton Journal

February 19, 2010

Courtesy The One Click Group

LONDON – British drug giant GlaxoSmithKline said on Tuesday it was working with health authorities who are probing the death of a schoolgirl following a cervical cancer vaccination.

The 14-year-old died on Monday after an adverse reaction to the Cervarix vaccine at her school in Coventry, central England, as part of a national vaccination to protect women against the disease.

Cervarix HPV Adverts are Untrue and Should be Banned

VacTruth.com

February 2, 2010
by Christina England

Cervical cancer kills around 940 women in the UK every year and the advertsmajority of these women are over the age of 45 years. Although shocking, this is a comparatively low figure,compared to those dying from other cancers, the highest rate of death being those dying from breast cancer which kills around 12,000 people a year. Despite these relatively low figures, the UK Government is keen to make sure that every girl over the age of twelve is vaccinated with the new HPV vaccine Cervarix which was introduced to the UK in September 2008.

Cervical cancer drug majors vie for India pie

Business Standard

Joe C Mathew / New Delhi January 04, 2010, 0:04 IST

US-based Merck is confident that its cervical cancer vaccine Gardasil will help it to secure a position among the country’s top five drug companies in the next five years. The world’s second largest drug manufacturer currently ranks 30th in domestic sales.

“We expect Gardasil to play a key role in our India growth,” says Naveen Rao, head of medical affairs for Merck’s Asia Pacific Region. Merck wants Gardasil as catalyst for government’s plan to immunise India’s young women from cervical cancer.

Watchdog to issue notice to GSK on cancer vaccine ads

Livemint.com

The Wall Street Journal
India

December 17, 2009

New Delhi: India’s drugs regulator has put GlaxoSmithKline Plc’s (GSK) cervical cancer vaccine “awareness” advertisements under the scanner, following a similar move against emergency contraceptive commercials.

“We will issue a show-cause notice to GSK and also write to the state authorities about these ads. They (GSK) say the vaccine will be effective for cervical cancer. This kind of advertising is not allowed,” said Surinder Singh, drugs controller general of India. “The ad can send a wrong message to the public also that by getting this vaccine the cancer can be prevented. And these vaccines are not cheap.”

Protection from HPV Vaccine Lasts Longer than Six Years

By Todd Neale, Staff Writer, MedPage Today
Published: December 02, 2009
Reviewed by Zalman S. Agus, MD; Emeritus Professor
University of Pennsylvania School of Medicine.
Med Page Today

Cervarix, one of two FDA-approved vaccines against human papillomavirus (HPV), protects against infection for more than six years, researchers found.Through follow-up as long as 6.4 years, the vaccine had an efficacy of 95.3% for preventing infection with the two types of HPV most commonly implicated in cervical cancer — HPV-16 and -18, Barbara Romanowski, MD, of the University of Alberta in Edmonton, and colleagues reported online in The Lancet.

Romanowski is a member of the HPV-007 study group of GlaxoSmithKline, which makes the vaccine.

Batch of H1N1 vaccine pulled after bad reactions

CTV News

Manitoba, Canada

November 20, 2009

More than 100,000 doses of the H1N1 vaccine are being withdrawn across the country, after Manitoba health officials announced Thursday they’d noticed a higher-than-usual number of allergic reactions from one batch.

Vaccine manufacturer GlaxoSmithKline has asked several provinces to set aside the 170,000 doses from the questionable batch.

FDA OKs New HPV Vaccine Cervarix

Cervarix Is Second Human Papillomavirus Vaccine Approved to Help Prevent Cervical Cancer

By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD

Oct. 16, 2009 — The FDA approved the human papillomavirus (HPV) vaccine Cervarix for use in girls and young women ages 10-25 to help prevent cervical cancer.

Cervarix targets two HPV strains, HPV 16 and HPV 18, which are leading causes of cervical cancer. Cervarix is approved to help prevent cervical precancers and cervical cancers associated with those two types of HPV.

HPV infection is common; the virus is sexually transmitted. Most women who get infected don’t develop cervical cancer, and there are other causes of cervical cancer.

Welcome to the Sunday Glaxo – Big Pharma & Media in Bed Together

Comment from Leslie

A lot of flurry going on the past few days about the media in the UK – Diane Harper’s “retraction of comments” and some pseudo-journalist named Ben who hides behind a Frankenstein mask on his articles. My colleague the UK shed some light on the whole situation when she brought this article to my attention that appeared in the Feb 25, 2009 blog post on Child Health Safety
Child Health Safety
February 25, 2009

MMR vaccine manufacturer GlaxoSmithKline has appointed to its Board the head of News International James Murdoch. Murdoch is also boss of The Sunday Times, London, England publisher of stories by freelance journalist Brian Deer to discredit research into the link between MMR vaccine and autism in the US and UK [James Murdoch joins Glaxo board - Andrew Jack and Ben Fenton Financial Times 2 February 2009].

Alliance For Natural Health Call for an Urgent Scientific Inquiry Into The HPV Vaccine Used In The UK

Press Release
For immediate release
9th October 2009

ALLIANCE FOR NATURAL HEALTH CALL FOR AN
URGENT SCIENTIFIC
INQUIRY INTO THE HPV VACCINE USED IN THE UK

The Alliance for Natural Health today is calling on all Members of Parliament in the UK to help stimulate an independent and transparent scientific inquiry on the safety of the HPV vaccine.

Reports of serious and even lethal adverse reactions to the Human Papilloma Virus (HPV) vaccine, Cervarix, manufactured by GlaxoSmithKline, raises grave concern over the safety of the vaccine. While its closely related vaccine, Gardasil, manufactured by Merck, is recognised by the US Centers for Disease Control (CDC) to trigger severe reactions, namely hospitalisation, permanent disability, life‐threatening illness or death, equivalent data in the UK appears not to be publicly available.

What has cervical cancer drug done to our girls?

Times Online
October 4, 2009
After one child’s death, we talk to parents who blame the vaccination for serious illnesses in their daughters

A year ago Rebecca Ramagge was a happy, sporty teenager, a high achiever at school and a tournament-level tennis player. Today she’s a 13-year-old crippled with chronic fatigue syndrome who has been laid up in bed for seven months and needs her mother’s help to tackle such basic tasks as brushing her hair and getting dressed.